Canvas Wealth Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Canvas Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$548.35 - $738.84 $182,600 - $246,033	-333 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$595.12 - $698.43 $332,076 - $389,723	-558 Reduced 62.63%	333 $220,000
Q4 2021 Jan 19, 2022	SELL	$543.48 - $670.97 $40,761 - $50,322	-75 Reduced 7.76%	891 $563,000
Q3 2021 Oct 15, 2021	SELL	$574.03 - $680.96 $22,961 - $27,238	-40 Reduced 3.98%	966 $585,000
Q2 2021 Aug 02, 2021	BUY	$472.8 - $558.54 $475,636 - $561,891	1,006 New	1,006 $562,000

1,535

83.8M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Canvas Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Canvas Wealth Advisors, LLC with notifications on news.